1 Hypovitaminosis A from inadequate vitA intake causes hai
2 ounts for poor antibody-mediated immunity in
hypovitaminosis A, since IFN-gamma in relatively small a
3 In the RYGB group, 13 patients developed
hypovitaminosis B(12) and 2 patients required reoperatio
4 Hypovitaminosis C and D are highly prevalent in acute-ca
5 pitalized patients with a high prevalence of
hypovitaminosis C and D.
6 pitalized patients with a high prevalence of
hypovitaminosis C and D.
7 Subjects with
hypovitaminosis D (<20 ng/mL) had a greater prevalence o
8 metabolic syndrome than did subjects without
hypovitaminosis D (30% compared with 11%; P = 0.0076).
9 Reports of
hypovitaminosis D among adults in the United States have
10 examined the prevalence and determinants of
hypovitaminosis D among African American and white women
11 The high prevalence of
hypovitaminosis D among African American women warrants
12 National data on
hypovitaminosis D among children are not yet available.
13 The determinants of
hypovitaminosis D among women should be considered when
14 There was no association between
hypovitaminosis D and either bone mineral density (P = 0
15 Reports of a high prevalence of
hypovitaminosis D and its association with increased ris
16 aviolet-light exposure, and risk factors for
hypovitaminosis D and measured serum 25-hydroxyvitamin D
17 The causal nature of the association between
hypovitaminosis D and poor cognitive function in mid- to
18 Hypovitaminosis D and reduced IGF-1 are associated, indi
19 by environmental factors such as pathogens,
hypovitaminosis D and smoking, may be a critical initiat
20 Subjects with
hypovitaminosis D are at higher risk of insulin resistan
21 bjects with vitamin D deficiency, those with
hypovitaminosis D had a 7.3% higher BMD (adjusted percen
22 Although
hypovitaminosis D has been detected frequently in elderl
23 In apparent contrast,
hypovitaminosis D has been reported in patients with pri
24 ebound status were independent predictors of
hypovitaminosis D in a multivariate model.
25 mined the prevalence of and risk factors for
hypovitaminosis D in children, adolescents, and young ad
26 has led to concerns about the prevalence of
hypovitaminosis D in many parts of the world.
27 We observed a high incidence of
hypovitaminosis D in patients with IBD.
28 Prevalence of
hypovitaminosis D in the general population was alarming
29 We aimed to determine the prevalence of
hypovitaminosis D in the white British population and to
30 ut few studies have examined determinants of
hypovitaminosis D in this population.
31 Hypovitaminosis D is associated with many features of th
32 Hypovitaminosis D is common in general medical inpatient
33 Hypovitaminosis D is prevalent among individuals with ga
34 Hypovitaminosis D may be a risk factor for lung dysfunct
35 ating epidemiological evidence suggests that
hypovitaminosis D may be associated with type 2 diabetes
36 insulin sensitivity and a negative effect of
hypovitaminosis D on beta cell function.
37 f the patients, and 58% of the patients with
hypovitaminosis D presented with delayed bone mineraliza
38 The prevalence of
hypovitaminosis D was 42.4 +/- 3.1% ( +/- SE) among Afri
39 Hypovitaminosis D was associated with noninfectious uvei
40 n this sample of pediatric patients with CD,
hypovitaminosis D was common and was associated with the
41 Hypovitaminosis D was defined as a serum 25-hydroxyvitam
42 Hypovitaminosis D was defined as a serum concentration o
43 ia, 26% presented with hypophosphatemia, and
hypovitaminosis D was detected in 63%.
44 The prevalence of
hypovitaminosis D was highest during the winter and spri
45 Among African Americans,
hypovitaminosis D was independently associated with cons
46 Hypovitaminosis D was most prevalent during the winter (
47 Hypovitaminosis D was observed in 55.14% of patients wit
48 mycin inhibitor-based immunosuppression, and
hypovitaminosis D were associated with PTMS.
49 Vitamin D deficiency (
hypovitaminosis D) causes osteomalacia and poor long bon
50 0 nmol/L, which is considered deficient (ie,
hypovitaminosis D).
51 5(OH)D levels 16-32 ng/ml were classified as
hypovitaminosis D, and 25(OH)D levels >32 ng/ml were cla
52 duals, 15% were vitamin D deficient, 51% had
hypovitaminosis D, and 34% were vitamin D replete.
53 Persistence of hyperparathyroidism,
hypovitaminosis D, and immunosuppressive drugs may have
54 on practices are not effective in preventing
hypovitaminosis D, particularly among vulnerable populat
55 years of age without known risk factors for
hypovitaminosis D, the prevalence of vitamin D deficienc
56 icacy of this approach in the elimination of
hypovitaminosis D, which is a widespread health disparit
57 ith IGF-1 was found only among those without
hypovitaminosis D.
58 om supplements (200 IU/d), 28.2 +/- 2.7% had
hypovitaminosis D.
59 demographic, and behavioral determinants of
hypovitaminosis D.
60 16% (95% CI: 9.3%, 23%) of the subjects had
hypovitaminosis D.
61 en and 20% of women, and 15% of patients had
hypovitaminosis D.
62 in were significant univariate predictors of
hypovitaminosis D.